Are you Dr. Abrams?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5073ten Oaks Rd
Clarksville, MD 21029Phone+1 240-276-6515
Summary
- Dr. Jeffrey Abrams, MD is an oncologist in Clarksville, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
- University of MarylandFellowship, Hematology and Medical Oncology, 1983 - 1984
- St Agnes HealthCareResidency, Internal Medicine, 1979 - 1982
- Catholic University of LeuvenClass of 1979
Certifications & Licensure
- MD State Medical License 1980 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 70 citationsRace, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes
Journal of the National Cancer Institute. 2021-04-06 - 11 citationsNetwork for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC).Helen X. Chen, Minkyung Song, Holden T. Maecker, Sacha Gnjatic, David Patton
Clinical Cancer Research. 2021-01-08 - 149 citationsMolecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)Keith T. Flaherty, Robert Gray, Alice P. Chen, Shuli Li, Lisa M. McShane
Journal of Clinical Oncology. 2020-10-13
Press Mentions
- Chemotherapy Is Losing Its LusterJune 20th, 2018
- TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from ChemotherapyJune 4th, 2018
- Big Returns on Small Cancer Research Investment, Study SuggestsJune 7th, 2017
- Join now to see all
Professional Memberships
- Member